Rong Chen, PhD

Editorial Board Member

Department of Physiology & Pharmacology
Wake Forest University, USA

Contact Rong Chen, PhD

Department / University Information


Dr. Rong Chen is a molecular and behavioral neuropharmacologist with nearly 15 years of experience conducting research on rodent models of substance abuse. Rong Chen current research focuses on studying the molecular mechanisms of the dopaminergic and serotonergic system in psycostimulant abuse. Dr. Chen use behavioral, molecular, genetic, and confocal microscopic approaches to investigate the functional changes of presynaptic monoamine transporters and autoreceptors upon acute and chronic psychostimulant exposure. Furthermore, Dr. Chen also interested in identifying novel adaptor proteins for transporters and autoreceptors in regulation of their function, trafficking and signaling

Research Interest

Dr. Rong Chen's research interests include: Molecular and Behavioral neuropharmacology, Substance abuse.


1. What makes an article top quality? 

Response: Papers applying novel technology and novel compounds, identifying novel targets, or have high clinical relevance.

2. Do you think that journals determine research trends?

Response: No, researchers determine the trend.

3. What makes a good position paper?

Response: A good position paper is an essay that incorporates all sides of the story, points out pros and cons, and importantly, future directions.

4. What are the qualities you look for in an article?

Response: Novel technology, novel concepts, novel targets and clinical relevance.

5. Can you give us a broad indication of the types of themes a scientific journal should cover?

Response: It depends on the mission of the journal.

6. What sorts of research methods and frameworks do you expect people to use, and how will they balance conceptual and applied research?

Response: It depends on what type of research.  Research methods are vehicles for authors to demonstrate their conceptual work.

7. How would you describe the journal’s mission and editorial objectives to our readers?

Response: Understand aspects that are involved in the addiction process, identify potential future targets and relate to clinical practice.

8. If you could be granted dream articles, what would they be on?

Response: Compounds that are effective in human clinical trial for treatment of psychostimulant addiction.

9. Are there any particular areas which you would like to see, or expect to see, collaborate?

Response: a)    The current status on drug treatment of drug addiction.  
                     b)    What are the drugs that are in the clinical use and what are the efficacies?

10. How does the research published percolate through to practitioners?

Response: It is far disconnected at this moment.  I am not sure how practitioners become aware of basic research.

11. How can a publisher ensure the authors/readers a rigorous peer review and quality control?

Response: Assign papers to appropriate editors and reviewers who have expertise in the relevant research area.

12. Your editorial policy is to be eclectic and welcome perspectives from other disciplines and schools. How does this translate into the types of contributions you encourage?

Response: Although my expertise is molecular/cellular pharmacology, I read all papers related to drug addiction field. I do like papers with both behavioural and molecular aspects.

13. What do you see as the merits of journals, as opposed to book series, as a means of scholarly communications?

Response: Papers do not have to be thorough, but are more recent and relevant.

14. How do you differentiate Journal of Addictive Behaviors, Therapy & Rehabilitation with other journals in the field?

Response: At this moment, there is no difference.  However, the journal could start a special column in each issue with one or two focuses throughout the year to attract certain population of audience.

Related Publications